ZyVersa Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $15 | $15 |
Gross Profit | -2 | -10 | 13 | |
EBITDA | -2,267 | -2,751 | -2,816 | -1,773 |
EBIT | -2,269 | -2,753 | -2,826 | -1,776 |
Net Income | -2,401,256 | -2,763 | -2,826 | -13,338 |
Net Change In Cash | 0 | 0 | 15 | 15 |
Free Cash Flow | -3,078,600 | -1,914 | -3,776 | -2,787 |
Cash | 122 | 119 | 2,033 | 3,137 |
Basic Shares | 9,883 | 834 | 623 | 4,052 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -10 | -10 | -10 | -10 |
EBITDA | -107,743 | -11,671 | -7,252 | -12,156 |
EBIT | -107,753 | -11,682 | -7,262 | -12,166 |
Net Income | -98,297 | -759,097 | -8,905 | -13,199 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,720 | -1,494 | -5,076 | -5,109 |
Cash | 3,137 | 5,902 | 328 | 174 |
Basic Shares | 97 | 25 | 46 | 46 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$2.43 |
2024-06-30 | -$3.31 |
2024-03-31 | -$4.53 |
2023-12-31 | -$13.68 |
